Predictors for local invasive recurrence of ductal carcinoma in situ of the breast: a meta analysis
The introduction of mammographic screening has considerably increased the detection rate of ductal carcinoma in situ (DCIS) which has a high probability of recurrence. We carried out a meta analysis to evaluate the predictive factors including biomarkers, tumor characteristics, and modes of detection on the risk of local invasive recurrence (LIR) following DCIS. Searches were performed in PubMed and EMBASE up to 8 July 2014. Risk estimates (hazard ratios, odds ratios, and relative risks) and their 95% confidence intervals (CIs) were extracted to calculate the strength of the associations between predictive factors and the risk of LIR after treatment of DCIS. STATA 12.0 was used to combine results in this meta analysis. A total of 18 articles were included in the analysis. Pooled risk estimates and 95% CIs were 1.36 (1.04 1.69) for the positive margin, 1.38 (1.12 1.63) for the nonscreening detection method, 1.04 (0.84 1.24) for high nuclear grade 1, 1.32 (0.98 1.66) for intermediate nuclear grade 2, 1.18 (0.98 1.37) for comedonecrosis, 1.00 (0.92 1.08) for large tumor size, 1.34 (0.82 1.87) for multifocality, 0.74 (0.36 1.12) for estrogen receptor positive tumors, 0.89 (0.47 1.31) for progesterone receptor positive tumors, and 1.25 (0.7 1.81) for HER2/neu positive tumors. Positive margin and non screening detected cancers were associated with a higher risk of LIR following DCIS. These predictive factors, after further validation, could be considered to tailor treatment for individual patients.
European journal of cancer prevention the official journal of the European Cancer Prevention Organisation